PARVIN SALARI: Open Payments
NPI 1740650712 · CATONSVILLE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,561 in 65 payments from 12 companies in 2025. Trend: 2023 $660 · 2024 $492 · 2025 $1,561
Food & beverage: $1,561
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 22 | $453 |
| ABBVIE INC. | 15 | $291 |
| UCB, Inc. | 5 | $193 |
| Novartis Pharmaceuticals Corporation | 5 | $156 |
| Janssen Biotech, Inc. | 4 | $120 |
| PFIZER INC. | 5 | $113 |
| GlaxoSmithKline, LLC. | 3 | $78 |
| Organon LLC | 2 | $47 |
| Bioventus LLC | 1 | $38 |
| AstraZeneca Pharmaceuticals LP | 1 | $29 |
Products named: ENBREL, Bimzelx, RINVOQ, ILARIS, TREMFYA, XELJANZ, KRYSTEXXA, SKYRIZI.
Industry payments across MD — which companies pay providers there.
